PHARMACOPOEIAL APPROACHES TO RATIONING RESIDUAL ORGANIC SOLVENTS IN MEDICINES

DOI: https://doi.org/None
Issue: 
1
Year: 
2017

O.I. Teryoshkina, PhD (1); Professor T.A. Guskova (2), MD; Professor G.V. Ramenskaya (1), PhD; Professor I.A. Samylina (1), PhD 1-I.M. Sechenov First Moscow State Medical University; 8, Trubetskaya St., Build. 2, Moscow 119991, Russian Federation; 2-Research Centre for Quality Control, Nonprofit Partnership for Public Health; 7, Myasnitskaya St., Build. 11, Moscow 101000, Russian Federation

The presence of residual organic solvents (toxic impurities) may be hazardous to patients. Therefore, pharmacopoeias include articles (monographs) governing their definition and rationing. The contents of general pharmacopoeia articles of the State Pharmacopoeias of the Russian Federation, XII and XIII editions, monographs of the European Pharmacopoeia, and the U.S. Pharmacopoeia, their structures, and terminologies were comparatively analyzed. Two different approaches to rationing residual organic solvents in the active pharmaceutical substance, excipients, and medicines are noted. The paper shows a need for the further harmonization of Russian normative documents (NDs) for the impurities of residual organic solvents. It indicates that the draft NDs should include additional sections on methods for establishing a partial differential equation (PDE), by describing the principle in the determination of toxicity for each of the hazard classes, the formulas to calculate the PDE and all modifying factors. Emphasis is placed on the importance of complementing the draft with conceptual information sections.

Keywords: 
impurity rationing
residual organic solvents
drugs
pharmacopoeias
draft general pharmacopoeia article

References: 
  1. Gosudarstvennaya farmakopeya Rossiyskoy Federacii XII izd., ch. I. M.: Nauchnyy centr e`kspertizy sredstv medicinskogo primeneniya, 2008; 704.
  2. Gosudarstvennaya farmakopeya Rossiyskoy Federacii XIII izd. https://www.rosminzdrav.ru/ministry/61/11/materialy-po-deyatelnosti-deparatamenta/stranitsa-856/spisok-obschih-farmakopeynyh-statey
  3. Evropeyskaya farmakopeya 7.0 Oficial`noe izdanie Evropeyskoy farmakopei na russkom yazyke, 2011.
  4. Farmakopeya SShA. Nacional`nyy formulyar: izbrannye obnovleniya i vse novye materialy s USP 29-NF 24 po USP 33-NF 28 vklyuchitel`no: [per.c angl.]. M.:GE`OTAR-Media, 2012; 888.
  5. European pharmacopoeia, 8.0. Strasbourg: Council of Europe, Strasbourg, 2014; 2133.
  6. United States Pharmacopeia (USP 30) and the 25th edition of the National Formulary (NF 25) (e-book), 2007.
  7. Teryoshkina O.I., Gus`kova T.A. Mezhdunarodnyy opyt ocenki bezopasnosti primesnyh soedineniy v lekarstvennyh preparatah. Toksikologicheskiy vestnik, 2010; 5: 32–5.
  8. Teryoshkina O.I. Sovremennye kriterii ocenki bezopasnosti sostava lekarstvennyh preparatov. Biomedicina, 2011; 3: 119–24.
  9. SanPiN 2.3.2. 1078-01. Gigienicheskie trebovaniya bezopasnosti i pishhevoy cennosti pishhevyh produktov. http://snipov.net/database/c_3624467195_doc_4293855259.html